Yunnan Baiyao Group Co Ltd (000538) Balance Sheet
A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.
Yunnan Baiyao Group Co.,Ltd engages in the sale of pharmaceuticals, medicinal materials, health and daily chemical products in China.
Total Assets Chart for Yunnan Baiyao Group Co Ltd
Yunnan Baiyao Group Co Ltd (000538) total assets for FY2025 were CNY 54.3B, a 2.6% change from FY2024. Yunnan Baiyao Group Co Ltd's total assets grew from CNY 59.4M in 1991 to CNY 54.3B in 2025 (91237.4% over 34 years). Total assets compound annual growth rate: 5-year CAGR of -0.4%, 10-year CAGR of 10.9%, 20-year CAGR of 19.3%.
Total Assets (CNY)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- ¥91.03B
- Implied Share Price
- ¥51.02
- Enterprise Value
- ¥76.59B
- Revenue (TTM)
- ¥41.81B
- EBITDA
- ¥5.09B
- Profit Margin
- 12.49%
- Trailing P/E
- 17.47
- Forward P/E
- 21.37
- Price/Book (MRQ)
- 2.21
- Price/Sales (TTM)
- 2.18
- EV/EBITDA
- 11.68
- EV/Revenue
- 1.82
- Dividend Yield
- 3.12%
- Book Value
- ¥22.96
- Free Cash Flow (FY2025)
- ¥4.12B
- Free Cash Flow Yield
- 4.53%
Snapshot as of 5th September 2026 — not point-in-time controlled, may lag the live market by a few days.